References
- Tak PP, Kalden JR. Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther 2011;13 Suppl 1:S5.
- Senolt L, Vencovsky J, Pavelka K, Ospelt C, Gay S. Prospective new biological therapies for rheumatoid arthritis. Autoimmun Rev 2009;9:102-7. https://doi.org/10.1016/j.autrev.2009.03.010
- Lahmer T, Knopf A, Lanzl I, Heemann U, Thuermel K. Using TNF-alpha antagonist Adalimumab for treatment for multisystem sarcoidosis: a case study. Rheumatol Int 2011 Jun 5 [Epub]. DOI: 10.1007/s00296-011-1968-x.
- Javot L, Tala S, Scala-Bertola J, Massy N, Trenque T, Baldin B, et al. Sarcoidosis and anti-TNF: a paradoxical class effect? Analysis of the French pharmacovigilance system database and literature review. Therapie 2011;66:149-154. https://doi.org/10.2515/therapie/2011014
- Toussirot E, Pertuiset E, Kantelip B, Wendling D. Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases. Clin Exp Rheumatol 2008;26:471-5.
- Clementine RR, Lyman J, Zakem J, Mallepalli J, Lindsey S, Quinet R. Tumor necrosis factor-alpha antagonist-induced sarcoidosis. J Clin Rheumatol 2010;16:274-9. https://doi.org/10.1097/RHU.0b013e3181efa190
- Murdaca G, Colombo BM, Puppo F. Adalimumab for the treatment of immune-mediated diseases: an update on old and recent indications. Drugs Today (Barc) 2011;47:277-88. https://doi.org/10.1358/dot.2011.47.4.1576692
- Pink AE, Fonia A, Smith CH, Barker JN. The development of sarcoidosis on antitumour necrosis factor therapy: a paradox. Br J Dermatol 2010;163:648-9. https://doi.org/10.1111/j.1365-2133.2010.09843.x
- Ramos-Casals M, Roberto-Perez-Alvarez, Diaz-Lagares C, Cuadrado MJ, Khamashta MA; BIOGEAS Study Group. Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev 2010;9:188-93. https://doi.org/10.1016/j.autrev.2009.10.003
- Kerjouan M, Jouneau S, Lena H, Luraine R, Desrues B, Delaval P. Pulmonary sarcoidosis developing during treatment with etanercept. Rev Mal Respir 2011;28:360-4. https://doi.org/10.1016/j.rmr.2010.08.018
- Gifre L, Ruiz-Esquide V, Xaubet A, Gomez-Puerta JA, Hernandez MV, Sanmarti R. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review. Arch Bronconeumol 2011;47:208-12.
- Toussirot E, Pertuiset E, Kantelip B, Wendling D. Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases. Clin Exp Rheumatol 2008;26:471-5.
- Daien CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, Houvenagel E, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 2009;48:883-6. https://doi.org/10.1093/rheumatology/kep046
- Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-65. https://doi.org/10.1056/NEJMra071714
- Furst DE, Wallis R, Broder M, Beenhouwer DO. Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin Arthritis Rheum 2006;36:159-67. https://doi.org/10.1016/j.semarthrit.2006.02.001
Cited by
- A Case of Sarcoidosis That Improved upon Discontinuation of Etanercept vol.23, pp.3, 2011, https://doi.org/10.4078/jrd.2016.23.3.187